See What HealthDay Can Do For You
Contact Us

Moderate, Heavy Drinking Linked to Increased BP, HTN in T2DM

Odds of elevated blood pressure and stage 1, 2 hypertension increased with moderate drinking

man pouring into the glass

THURSDAY, Sept. 10, 2020 (HealthDay News) -- For individuals with type 2 diabetes, moderate and heavy drinking are associated with an increased risk for elevated blood pressure, stage 1 hypertension, and stage 2 hypertension, according to a study published online Sept. 9 in the Journal of the American Heart Association.

Jonathan J. Mayl, M.D., from the Wake Forest School of Medicine in Winston-Salem, North Carolina, and colleagues describe the association between alcohol consumption and prevalent hypertension among 10,200 participants with type 2 diabetes from the Action to Control Cardiovascular Risk in Diabetes trial. Alcohol consumption was classified as none, light (one to seven/week), moderate (eight to 14/week), and heavy (≥15 drinks/week).

The researchers observed no association for light alcohol consumption with elevated blood pressure or any stage of hypertension. Associations were seen for moderate alcohol consumption with elevated blood pressure and stage 1 and stage 2 hypertension (odds ratios, 1.79, 1.66, and 1.62, respectively). Associations were also seen for heavy alcohol consumption (odds ratios, 1.91, 2.49, and 3.04, respectively).

"Though light-to-moderate alcohol consumption may have positive effects on cardiovascular health in the general adult population, both moderate and heavy alcohol consumption appear to be independently associated with higher odds of high blood pressure among those with type 2 diabetes," a coauthor said in a statement.

Abstract/Full Text

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.